Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 442

Similar articles for PubMed (Select 22464811)

1.

Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents.

Papa A, Felice C, Marzo M, Andrisani G, Armuzzi A, Covino M, Mocci G, Pugliese D, De Vitis I, Gasbarrini A, Rapaccini GL, Guidi L.

J Crohns Colitis. 2013 Mar;7(2):113-9. doi: 10.1016/j.crohns.2012.03.001. Epub 2012 Mar 30.

PMID:
22464811
2.

Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.

Saravanan S, Velu V, Nandakumar S, Madhavan V, Shanmugasundaram U, Murugavel KG, Balakrishnan P, Kumarasamy N, Solomon S, Thyagarajan SP.

J Microbiol Immunol Infect. 2009 Apr;42(2):122-8.

PMID:
19597643
3.

Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.

Lan JL, Chen YM, Hsieh TY, Chen YH, Hsieh CW, Chen DY, Yang SS.

Ann Rheum Dis. 2011 Oct;70(10):1719-25. doi: 10.1136/ard.2010.148783. Epub 2011 Jun 29.

PMID:
21719446
4.

Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France.

Chevaux JB, Nani A, Oussalah A, Venard V, Bensenane M, Belle A, Gueant JL, Bigard MA, Bronowicki JP, Peyrin-Biroulet L.

Inflamm Bowel Dis. 2010 Jun;16(6):916-24. doi: 10.1002/ibd.21147.

PMID:
19885908
5.

HBV and HCV infection in Japanese dental care workers.

Nagao Y, Matsuoka H, Kawaguchi T, Ide T, Sata M.

Int J Mol Med. 2008 Jun;21(6):791-9.

PMID:
18506374
6.

Hepatitis B and C virus infection in Crohn's disease.

Biancone L, Pavia M, Del Vecchio Blanco G, D'Incà R, Castiglione F, De Nigris F, Doldo P, Cosco F, Vavassori P, Bresci GP, Arrigoni A, Cadau G, Monteleone I, Rispo A, Fries W, Mallardi B, Sturniolo GC, Pallone F; Italian Group for the Study of the Colon and Rectum (GISC).

Inflamm Bowel Dis. 2001 Nov;7(4):287-94.

PMID:
11720317
7.
8.

Isolated core antibody hepatitis B in sub-Saharan African immigrants.

Gibney KB, Torresi J, Lemoh C, Biggs BA.

J Med Virol. 2008 Sep;80(9):1565-9. doi: 10.1002/jmv.21267.

PMID:
18649341
9.

Antibody to hepatitis B core antigen as a screening test for occult hepatitis B virus infection in Egyptian chronic hepatitis C patients.

El-Sherif A, Abou-Shady M, Abou-Zeid H, Elwassief A, Elbahrawy A, Ueda Y, Chiba T, Hosney AM.

J Gastroenterol. 2009;44(4):359-64. doi: 10.1007/s00535-009-0020-3. Epub 2009 Mar 7.

PMID:
19271112
10.

HBV vaccination of HCV-infected patients with occult HBV infection and anti-HBc-positive blood donors.

Pereira JS, Gonçales NS, Silva C, Lazarini MS, Pavan MH, Fais VC, Gonçales Júnior FL.

Braz J Med Biol Res. 2006 Apr;39(4):525-31. Epub 2006 Apr 3.

11.

High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan.

Marusawa H, Osaki Y, Kimura T, Ito K, Yamashita Y, Eguchi T, Kudo M, Yamamoto Y, Kojima H, Seno H, Moriyasu F, Chiba T.

Gut. 1999 Aug;45(2):284-8.

12.

Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles.

Souza KP, Luz JA, Teles SA, Carneiro MA, Oliveira LA, Gomes AS, Dias MA, Gomes SA, Yoshida CF, Martins RM.

Mem Inst Oswaldo Cruz. 2003 Jul;98(5):599-603.

PMID:
13677340
13.

HCV genotype and "silent" HBV coinfection: two main risk factors for a more severe liver disease.

Sagnelli E, Coppola N, Scolastico C, Mogavero AR, Filippini P, Piccinino F.

J Med Virol. 2001 Jul;64(3):350-5.

PMID:
11424125
14.

Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection.

Zignego AL, Fontana R, Puliti S, Barbagli S, Monti M, Careccia G, Giannelli F, Giannini C, Buzzelli G, Brunetto MR, Bonino F, Gentilini P.

Arch Virol. 1997;142(3):535-44.

PMID:
9349299
15.

Outcome of hepatitis B and C virus infection on graft function after renal transplantation.

Behzad-Behbahani A, Mojiri A, Tabei SZ, Farhadi-Andarabi A, Pouransari R, Yaghobi R, Rahsaz M, Banihashemi M, Malek-Hosseini SA, Javid A, Bahador A, Reisjalali A, Behzadi S, Salehipour M, Salahl A, Davari R, Janghorban P, Torb A, Salah AR.

Transplant Proc. 2005 Sep;37(7):3045-7.

PMID:
16213299
16.

Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.

Sukriti, Pati NT, Sethi A, Agrawal K, Agrawal K, Kumar GT, Kumar M, Kaanan AT, Sarin SK.

J Gastroenterol Hepatol. 2008 Nov;23(11):1710-5. doi: 10.1111/j.1440-1746.2008.05483.x. Epub 2008 Aug 28.

PMID:
18761556
17.

Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.

Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A.

Trop Gastroenterol. 2007 Jan-Mar;28(1):19-23.

PMID:
17896605
18.
19.

Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy.

Loras C, Gisbert JP, Mínguez M, Merino O, Bujanda L, Saro C, Domenech E, Barrio J, Andreu M, Ordás I, Vida L, Bastida G, González-Huix F, Piqueras M, Ginard D, Calvet X, Gutiérrez A, Abad A, Torres M, Panés J, Chaparro M, Pascual I, Rodriguez-Carballeira M, Fernández-Bañares F, Viver JM, Esteve M; REPENTINA study; GETECCU (Grupo Español de Enfermedades de Crohn y Colitis Ulcerosa) Group.

Gut. 2010 Oct;59(10):1340-6. doi: 10.1136/gut.2010.208413. Epub 2010 Jun 24.

PMID:
20577000
20.

No evidence of hepatitis B virus activity in patients with anti-HBc antibody positivity with or without anti-hepatitis C virus antibody positivity.

Haushofer AC, Hauer R, Brunner H, Köller U, Trubert-Exinger D, Halbmayer WM, Koidl C, Kessler HH.

J Clin Virol. 2004 Apr;29(4):221-3.

PMID:
15018848
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk